Instructor, Medicine - Oncology, Stanford University Medical Center
Oncology
Dr. Alice C. Fan, MD
|
|
Give Review
Doctor Alice C. Fan, MD works in the field of Oncology. She graduated from Albany Medical College. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Alice C. Fan, MD has written publications. She has 15 publications published with PubMed. The lastest paper is: 'Alteration of the lipid profile in lymphomas induced by MYC overexpression.' Dr. Alice C. Fan is registered with Medicare and accepts Medicare payments.
Publications
- Alteration of the lipid profile in Lymphomas induced by MYC overexpression.
- BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.
- A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide.
- Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of Cancer.
- Treatment of higher risk Myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na.
- Definition of an enhanced Immune cell therapy in mice that can target stem-like lymphoma cells.
- CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.
- Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.
- Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.
- Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenoCarcinomas and lymphomas.
- Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced Lymphomagenesis.
- Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.
- Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
- Conditional animal models: a strategy to define when oncogenes will be effective targets to treat Cancer.
Schools
Albany Medical College
Brown University School Of Med
Stanford University
Conditions Treated
- Anemia
- Breast Cancer
- Carcinoma in Situ
- Immune Thrombocytopenic Purpura (ITP)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Brown University -
Albany Medical College
Hospital
-
Stanford Health Care
Helpful Reviews
Similar Doctors
|
|
Dr. Melinda L. Telli, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Allison W. Kurian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert W. Carlson, MD |
|
|
Dr. Harlan A. Pinto, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gilbert Chu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eric W. Humke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Klaus J. Porzig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Priya Chakravarthi, MD |
|
|
Dr. Gregory K. Behbehani, MD
This Doctor is OpenDoctor Recommended.
|